Supphachoke Khemla, Atibordee Meesing, Wantin Sribenjalux, & Ploenchan Chetchotisakd. (2023). Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. AboutScience Srl.
Chicago Style (17th ed.) CitationSupphachoke Khemla, Atibordee Meesing, Wantin Sribenjalux, and Ploenchan Chetchotisakd. Lipid Profiles of People with Human Immunodeficiency Virus with Dyslipidemia After Switching from Efavirenz to Dolutegravir. AboutScience Srl, 2023.
MLA (9th ed.) CitationSupphachoke Khemla, et al. Lipid Profiles of People with Human Immunodeficiency Virus with Dyslipidemia After Switching from Efavirenz to Dolutegravir. AboutScience Srl, 2023.
Warning: These citations may not always be 100% accurate.